Related Experiment Videos
Distal coronary hemoperfusion during percutaneous transluminal coronary angioplasty
E D de Muinck1, P den Heijer, R B van Dijk
1Catheterization Laboratory, University Hospital, Groningen, The Netherlands.
Insights
Distal coronary hemoperfusion during percutaneous transluminal coronary angioplasty (PTCA) can improve outcomes in complex lesions. However, pumps may be preferred over autoperfusion balloons for high-risk procedures to prevent hemodynamic collapse.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
Background:
- Distal coronary hemoperfusion during PTCA facilitates prolonged balloon inflation.
- This can improve results in complex lesions by tacking intimal dissections and reduce cardiogenic shock risk.
Purpose of the Study:
- To evaluate the role and limitations of distal coronary hemoperfusion during PTCA.
- To compare autoperfusion balloons and active perfusion systems for managing complex coronary lesions and high-risk PTCA.
Main Methods:
- Review of autoperfusion balloons and active perfusion systems in PTCA.
- Discussion of clinical applications, benefits, and limitations of distal perfusion techniques.
Main Results:
- Autoperfusion balloons are used for acute or threatened closure, but their flow rates may not fully resolve ischemia.
- Perfusion pumps may offer higher flow rates to prevent hemodynamic collapse but carry risks of hemolysis and vessel trauma.
Conclusions:
- Distal hemoperfusion can be beneficial in specific PTCA scenarios.
- Perfusion pumps may be superior for high-risk PTCA, despite potential complications. Further clinical studies are needed for stent implantation efficacy.
Abstract:
Distal coronary hemoperfusion during percutaneous transluminal coronary angioplasty (PTCA)-with an autoperfusion balloon or active system-facilitates prolonged balloon inflation. Prolonged inflations may tack up intimal dissections and improve the primary angioplasty result in complex lesions. Additionally, distal perfusion may reduce the likelihood of cardiogenic shock during high-risk PTCA. Autoperfusion balloons are most frequently used to treat acute or threatened closure. There currently is no prospective clinical study showing that stent implantation for this complication is more successful and more cost-effective. The blood flow rates through autoperfusion balloons may not abolish myocardial ischemia, and higher flow rates can often be achieved with pumps. Therefore, during high-risk PTCA, pumps may be preferred to prevent hemodynamic collapse. Clinical application of perfusion pumps is hampered by the risk for mechanical hemolysis during prolonged perfusion and the high velocity of the bloodstream that exits the PTCA catheter, causing distal vessel wall trauma.